99 related articles for article (PubMed ID: 761217)
1. Effects of N-trifluoroacetyladriamycin-14-valerate and related agents on DNA strand damage and thymidine incorporation in CCRF-CEM cells.
Kanter PM; Schwartz HS
Cancer Res; 1979 Feb; 39(2 Pt 1):448-51. PubMed ID: 761217
[TBL] [Abstract][Full Text] [Related]
2. Quantitative models for growth inhibition of human leukemia cells by antitumor anthracycline derivatives.
Kanter PM; Schwartz HS
Cancer Res; 1979 Sep; 39(9):3661-72. PubMed ID: 476691
[TBL] [Abstract][Full Text] [Related]
3. Comparative effects of adriamycin and N-trifluoroacetyladriamycin-14-valerate on cell kinetics, chromosomal damage, and macromolecular synthesis in vitro.
Krishan A; Dutt K; Israel M; Ganapathi R
Cancer Res; 1981 Jul; 41(7):2745-50. PubMed ID: 6972801
[TBL] [Abstract][Full Text] [Related]
4. Differential effect of the calmodulin inhibitor trifluoperazine on cellular accumulation, retention, and cytotoxicity of anthracyclines in doxorubicin (adriamycin)-resistant P388 mouse leukemia cells.
Ganapathi R; Grabowski D; Rouse W; Riegler F
Cancer Res; 1984 Nov; 44(11):5056-61. PubMed ID: 6488165
[TBL] [Abstract][Full Text] [Related]
5. Resistance and cross-resistance of cultured leukemia P388 cells to vincristine, adriamycin, adriamycin analogs, and actinomycin D.
Wilkoff LJ; Dulmadge EA
J Natl Cancer Inst; 1978 Dec; 61(6):1521-4. PubMed ID: 281559
[TBL] [Abstract][Full Text] [Related]
6. Protein-associated DNA breaks and DNA-protein cross-links caused by DNA nonbinding derivatives of adriamycin in L1210 cells.
Levin M; Silber R; Israel M; Goldfeder A; Khetarpal VK; Potmesil M
Cancer Res; 1981 Mar; 41(3):1006-10. PubMed ID: 7459847
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the sensitivities of human, canine, and murine hematopoietic precursor cells to adriamycin and N-trifluoroacetyladriamycin-14-valerate.
Marsh JC
Cancer Res; 1979 Feb; 39(2 Pt 1):360-4. PubMed ID: 761207
[TBL] [Abstract][Full Text] [Related]
8. A differential interaction of daunomycin, adriamycin, and N-trifluoroacetyladriamycin 14-valerate with mouse peritoneal macrophages.
Facchinetti T; Raz A; Goldman R
Cancer Res; 1978 Nov; 38(11 Pt 1):3944-9. PubMed ID: 212183
[TBL] [Abstract][Full Text] [Related]
9. Relationship between effects on nucleic acid synthesis in cell cultures and cytotoxicity of 4-demethoxy derivatives of daunorubicin and adriamycin.
Supino R; Necco A; Dasdia T; Casazza AM; Di Marco A
Cancer Res; 1977 Dec; 37(12):4523-8. PubMed ID: 922737
[TBL] [Abstract][Full Text] [Related]
10. N-trifluoroacetyladriamycin-14-valerate, an analog with greater experimental antitumor activity and less toxicity than adriamycin.
Israel M; Modest EJ; Frei E
Cancer Res; 1975 May; 35(5):1365-8. PubMed ID: 1054622
[TBL] [Abstract][Full Text] [Related]
11. Alkali-labile regions and strand breaks in DNA from cells treated with daunorubicin.
Schwartz HS
J Med; 1976; 7(1):33-46. PubMed ID: 1064678
[TBL] [Abstract][Full Text] [Related]
12. Metabolic activation of N-acylanthracyclines precedes their interaction with DNA topoisomerase II.
Silber R; Liu LF; Israel M; Bodley AL; Hsiang YH; Kirschenbaum S; Sweatman TW; Seshadri R; Potmesil M
NCI Monogr; 1987; (4):111-5. PubMed ID: 3041237
[TBL] [Abstract][Full Text] [Related]
13. Modulation of adriamycin and N-trifluoroacetyladriamycin-14-valerate induced effects on cell cycle traverse and cytotoxicity in P388 mouse leukemia cells by caffeine and the calmodulin inhibitor trifluoperazine.
Ganapathi R; Grabowski D; Schmidt H; Yen A; Iliakis G
Cancer Res; 1986 Nov; 46(11):5553-7. PubMed ID: 3756902
[TBL] [Abstract][Full Text] [Related]
14. Effect of sodium chloride concentration on adriamycin and N-trifluoroacetyladriamycin-14-valerate (AD32)-induced cell killing and DNA damage in Chinese hamster V79 cells.
Iliakis G; Lazar W
Cancer Res; 1987 Apr; 47(7):1853-8. PubMed ID: 3815376
[TBL] [Abstract][Full Text] [Related]
15. Effect of adriamycin and analogs on the nuclear fluorescence of propidium iodide-stained cells.
Krishan A; Ganapathi RN; Israel M
Cancer Res; 1978 Nov; 38(11 Pt 1):3656-62. PubMed ID: 698925
[TBL] [Abstract][Full Text] [Related]
16. N-trifluoroacetyladriamycin-14-valerate and adriamycin induced DNA damage in the RPMI-6410 human lymphoblastoid cell line.
Brox L; Gowans B; Belch A
Can J Biochem; 1980 Sep; 58(9):720-5. PubMed ID: 7006761
[TBL] [Abstract][Full Text] [Related]
17. Relationship between activity and amino sugar stereochemistry of daunorubicin and adriamycin derivatives.
Di Marco A; Casazza AM; Gambetta R; Supino R; Zunino F
Cancer Res; 1976 Jun; 36(6):1962-6. PubMed ID: 773533
[TBL] [Abstract][Full Text] [Related]
18. [Adriamycin effects of PHA-stimulated lymphocytes].
Lutz D; Haist B; Stacher A
Int J Clin Pharmacol Biopharm; 1975 Apr; 11(3):226-31. PubMed ID: 1150368
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxicity and DNA strand breaks by 5-iminodaunorubicin in mouse leukemia L1210 cells: comparison with adriamycin and 4'-(9-acridinylamino)methanesulfon-m-anisidide.
Zwelling LA; Kerrigan D; Michaels S
Cancer Res; 1982 Jul; 42(7):2687-91. PubMed ID: 6896293
[TBL] [Abstract][Full Text] [Related]
20. DNA topoisomerase II-mediated interaction of doxorubicin and daunorubicin congeners with DNA.
Bodley A; Liu LF; Israel M; Seshadri R; Koseki Y; Giuliani FC; Kirschenbaum S; Silber R; Potmesil M
Cancer Res; 1989 Nov; 49(21):5969-78. PubMed ID: 2551497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
